Scarica l'app Stockscreener
3.71
7.25%
-0.29
Dopo l'orario di chiusura:
3.75
0.04
+1.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Is Rocket Pharmaceuticals Inc. Equity Warrant stock positioned well for digital economyWeekly Gains Report & Daily Momentum Trading Reports - Trung tâm Dự báo KTTV quốc gia
What’s next for Rocket Pharmaceuticals Inc. stock priceWeekly Trend Summary & Weekly Watchlist for Consistent Profits - newser.com
Rocket Pharmaceuticals Officer Sells Shares - TradingView
RCKT Form 4: Insider sells 28,918 shares; 67,006 shares remain - Stock Titan
RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - sharewise.com
Rocket Pharma jumps as gene therapy undergoes FDA review again - MSN
Chart based analysis of Rocket Pharmaceuticals Inc. trendsJuly 2025 Analyst Calls & Real-Time Market Sentiment Reports - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reports2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
What dividend safety score for Rocket Pharmaceuticals Inc. stockDollar Strength & Real-Time Buy Signal Alerts - newser.com
Will a bounce in Rocket Pharmaceuticals Inc. offer an exit2025 Key Lessons & Low Risk High Win Rate Picks - newser.com
Possible Signal As Rocket Pharmaceuticals Insiders Sell US$1.1m In Stock - simplywall.st
Analyzing Rocket Pharmaceuticals Inc. Equity Warrant with risk reward ratio chartsJuly 2025 Final Week & Weekly Top Performers Watchlists - newser.com
RCKT: Chardan Capital Maintains 'Buy' Rating with $11 PT | RCKT Stock News - GuruFocus
FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock - Benzinga
Rocket Pharmaceuticals Shares Surge after FDA Accepts Drug Application Resubmission - MarketScreener
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment o - PharmiWeb.com
Rocket Pharmaceuticals (RCKT) Resubmitted Gene Therapy Applicati - GuruFocus
Rocket Pharma says gene therapy gets FDA review (RCKT:NASDAQ) - Seeking Alpha
Rocket Pharma Gets FDA Review Date for Severe Immune Disorder Drug Candidate - MarketScreener
FDA Accepts Rocket Pharmaceuticals' Resubmission for Kresladi Ge - GuruFocus
FDA Accepts Rocket Pharmaceuticals' BLA Resubmission for Rare Genetic Disorder Treatment - MarketScreener
Why Rocket Pharma Is Rising In Pre-market? - Nasdaq
Rocket Pharmaceuticals’ FDA Resubmission for KRESLADI™ Accepted - TipRanks
FDA accepts Rocket Pharmaceuticals’ gene therapy BLA for rare disease - Investing.com
Rocket Pharma (RCKT) gets FDA date; PRV eligible if approved - Stock Titan
FDA accepts Rocket Pharmaceuticals' resubmitted gene therapy application - StreetInsider
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) - Business Wire
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to inflationary pressuresMarket Performance Recap & Risk Controlled Stock Alerts - newser.com
Will Rocket Pharmaceuticals Inc. stock go up soonJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
Lobbying Update: $30,000 of ROCKET PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
Heatmap analysis for Rocket Pharmaceuticals Inc. Equity Warrant and competitors2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com
Why Rocket Pharmaceuticals Inc. stock is in analyst buy zoneMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Can a trend reversal in Rocket Pharmaceuticals Inc. Equity Warrant lead to recoveryDip Buying & Stock Portfolio Risk Management - newser.com
Rocket Pharmaceuticals Inc (9IP1.DU) stock price, news, quote and history - Yahoo
Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Rocket Pharmaceuticals Inc. Equity Warrant stock bottoming outQuarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Rocket Pharmaceuticals Inc (9IP1.DU) Stock Price, News, Quote & History - Yahoo
Rocket Pharmaceuticals Inc (9IP1.DU) Latest Press Releases & Corporate News - Yahoo
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Should you hold or exit Rocket Pharmaceuticals Inc. now2025 Trading Volume Trends & Real-Time Buy Signal Notifications - newser.com
Published on: 2025-10-10 06:17:17 - newser.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Published on: 2025-10-10 04:39:16 - newser.com
Building trade automation scripts for Rocket Pharmaceuticals Inc. Equity Warrant2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc. Equity WarrantMarket Volume Report & High Win Rate Trade Alerts - newser.com
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):